MLYS insider buying – Mineralys Therapeutics, Inc.

16 insider purchases since 2016 worth $134.6M by 9 different insiders. Last 12 months: 1 purchases, $8.8M. Most recent filing: 2026-03-31.

Where insiders bought and sold MLYS – last 5 yearsCEO / officers Directors Funds & 10% owners Sales

Same time range as the chart above - each mark sits under the week of the trade. Circles = purchases (height = price paid, size = amount), red triangles = open-market sales of $50k+. Prices as reported, not adjusted for later stock splits.

Purchases are open-market buys (SEC Form 4, code "P") - insiders paying with their own money. Sales are open-market sales (code "S") of $50,000 or more; many sales are pre-planned (Rule 10b5-1) or made for taxes and diversification. Each row links to the original filing.

Bought, sold, still holding?

InsiderBoughtFirst / last buySold since 2016Holds now*Status
AKKARAJU SRINIVAS
Director
$38.1M
3× · 2,125,735 sh
2023-02-14
2025-09-04
–5,877,218 shares
as of 2026-02-20
Holds - never sold
RA Capital Nexus Fund III, L.P.
Director
$37.5M
2× · 2,546,296 sh
2023-02-14
2025-03-13
–4,280,051 shares
as of 2025-03-17
Holds - never sold
RA CAPITAL MANAGEMENT, L.P.
Director
$30.0M
1× · 1,176,470 sh
2025-09-04
2025-09-04
–5,456,521 shares
as of 2025-09-08
Holds - never sold
Shah Rajeev M.
Director
$8.8M
1× · 369,000 sh
2026-03-27
2026-03-27
–5,825,521 shares
as of 2026-03-31
Holds - never sold
Slingsby Brian Taylor
Director
$7.5M
2× · 509,259 sh
2023-02-14
2025-03-13
2× · $10.2M
last 2026-09-22
7,805,718 shares
as of 2026-09-24
Sold part
Samsara BioCapital, L.P.
10% Owner
$7.5M
1× · 555,555 sh
2024-02-12
2024-02-12
–5,674,916 shares
as of 2025-03-17
Holds - never sold
HBM Healthcare Investments (Cayman) Ltd.
10% Owner
$5.0M
1× · 312,500 sh
2023-02-14
2023-02-14
–3,218,106 shares
as of 2023-02-16
Holds - never sold
Congleton Jon
CEO
$105,557
4× · 10,750 sh
2023-08-11
2023-11-22
14× · $17.4M
last 2026-07-13
603,621 shares
as of 2026-07-15
Sold part
Levy Adam Scott
CFO
$100,000
1× · 6,250 sh
2023-02-14
2023-02-14
10× · $9.2M
last 2026-01-12
48,538 shares
as of 2026-02-20
Sold part

* Shares held after the insider's most recent SEC filing for this company (all share classes, direct and indirect). If an insider stops filing, later changes are not known.

Insider buying and selling by year

YearPurchasesBoughtBuyersSalesSold
20261$8.8M129$26.0M
20255$74.1M422$65.8M
20241$7.5M110$11.1M
20239$44.2M61$3.0M

Insider purchases

FiledInsiderRoleSharesAvg priceValueHoldingsFiling
2026-03-31Shah Rajeev M.Director369,000$23.75$8.8M+6.8%SEC
2025-09-08RA CAPITAL MANAGEMENT, L.P.Director1,176,470$25.50$30.0M+27.5%SEC
2025-09-08AKKARAJU SRINIVASDirector588,235$25.50$15.0MSEC
2025-04-25Slingsby Brian TaylorDirector259,259$13.50$3.5M+3.0%SEC
2025-03-17RA Capital Nexus Fund III, L.P.Director1,296,296$13.50$17.5M+43.4%SEC
2025-03-17AKKARAJU SRINIVASDirector600,000$13.50$8.1M+11.8%SEC
2024-02-14Samsara BioCapital, L.P.10% Owner555,555$13.50$7.5M+12.3%SEC
2023-11-27Congleton JonCEO4,250$5.97$25,372+0.4%SEC
2023-09-08Congleton JonCEO2,250$12.08$27,180+0.2%SEC
2023-08-21Congleton JonCEO2,250$12.10$27,225+0.2%SEC
2023-08-11Congleton JonCEO2,000$12.89$25,780+0.2%SEC
2023-02-16Slingsby Brian TaylorDirector250,000$16.00$4.0M+2.8%SEC
2023-02-16RA Capital Nexus Fund III, L.P.Director1,250,000$16.00$20.0M+202.5%SEC
2023-02-16Levy Adam ScottCFO6,250$16.00$100,000+1.8%SEC
2023-02-16HBM Healthcare Investments (Cayman) Ltd.10% Owner312,500$16.00$5.0M+10.8%SEC
2023-02-16AKKARAJU SRINIVASDirector937,500$16.00$15.0M+26.2%SEC

Insider sales

FiledInsiderRoleSharesAvg priceValueTypeFiling
2026-09-24Slingsby Brian TaylorDirector104,320$28.81$3.0MSaleSEC
2026-09-22Warren EricOfficer7,438$28.12$209,157Pre-planned (10b5-1)SEC
2026-09-17Karydas DaphneDirector3,000$28.58$85,740Pre-planned (10b5-1)SEC
2026-08-25Warren EricOfficer7,437$25.98$193,213Pre-planned (10b5-1)SEC
2026-08-12Rodman David MalcomOfficer2,170$27.09$58,785Pre-planned (10b5-1)SEC
2026-07-23Warren EricOfficer7,438$26.87$199,859Pre-planned (10b5-1)SEC
2026-07-15Rodman David MalcomOfficer20,407$27.28$556,667Pre-planned (10b5-1)SEC
2026-07-15Congleton JonCEO10,700$27.24$291,468Pre-planned (10b5-1)SEC
2026-07-10Rodman David MalcomOfficer2,171$30.30$65,781Pre-planned (10b5-1)SEC
2026-06-30Congleton JonCEO75,000$26.14$2.0MPre-planned (10b5-1)SEC
2026-06-30Warren EricOfficer104,124$25.90$2.7MPre-planned (10b5-1)SEC
2026-06-17Karydas DaphneDirector3,000$25.00$75,000Pre-planned (10b5-1)SEC
2026-06-17Rodman David MalcomOfficer14,474$24.19$350,081Pre-planned (10b5-1)SEC
2026-06-12Rodman David MalcomOfficer8,519$24.20$206,182Pre-planned (10b5-1)SEC
2026-05-13Rodman David MalcomOfficer22,575$28.91$652,598Pre-planned (10b5-1)SEC

Showing the latest 15 of 62 sales of $50,000+ since 2016.

Compiled automatically from public SEC filings. Not investment advice. Get every new insider purchase in the daily report.

Get every new insider purchase the day it's filed

Daily report with all SEC insider buys, cluster buys, company events and the crypto money-flow radar.

Get started free